Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ashwini S Nagaraj"'
Autor:
Iris A. K. Lähdeniemi, Jennifer R. Devlin, Ashwini S. Nagaraj, Sarang S. Talwelkar, Jie Bao, Nora Linnavirta, Ceren Şeref Vujaklija, Elina A. Kiss, Annabrita Hemmes, Emmy W. Verschuren
Publikováno v:
Biology Open, Vol 11, Iss 12 (2022)
Externí odkaz:
https://doaj.org/article/c0f7ba253ae148818c5beb30806d7339
Autor:
Ashwini S. Nagaraj, Jenni Lahtela, Annabrita Hemmes, Teijo Pellinen, Sami Blom, Jennifer R. Devlin, Kaisa Salmenkivi, Olli Kallioniemi, Mikko I. Mäyränpää, Katja Närhi, Emmy W. Verschuren
Publikováno v:
Cell Reports, Vol 18, Iss 3, Pp 673-684 (2017)
Lung cancers exhibit pronounced functional heterogeneity, confounding precision medicine. We studied how the cell of origin contributes to phenotypic heterogeneity following conditional expression of KrasG12D and loss of Lkb1 (Kras;Lkb1). Using proge
Externí odkaz:
https://doaj.org/article/4865c03d589649f090200e998d1e2cd4
Autor:
Emmy W. Verschuren, Krister Wennerberg, Mikko I. Mäyränpää, Kaisa Salmenkivi, Pipsa Saharinen, Elina A. Kiss, Swapnil Potdar, Annabrita Hemmes, Jennifer R. Devlin, Ashwini S. Nagaraj, Sarang S. Talwelkar
Table_S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4275035dd0425cbf4d4e396a83cab57f
https://doi.org/10.1158/1535-7163.22509204
https://doi.org/10.1158/1535-7163.22509204
Autor:
Emmy W. Verschuren, Krister Wennerberg, Mikko I. Mäyränpää, Kaisa Salmenkivi, Pipsa Saharinen, Elina A. Kiss, Swapnil Potdar, Annabrita Hemmes, Jennifer R. Devlin, Ashwini S. Nagaraj, Sarang S. Talwelkar
Supplementary text and figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25da8709577071f02aaeaf9cd8b88369
https://doi.org/10.1158/1535-7163.22509210.v1
https://doi.org/10.1158/1535-7163.22509210.v1
Autor:
Emmy W. Verschuren, Krister Wennerberg, Mikko I. Mäyränpää, Kaisa Salmenkivi, Pipsa Saharinen, Elina A. Kiss, Swapnil Potdar, Annabrita Hemmes, Jennifer R. Devlin, Ashwini S. Nagaraj, Sarang S. Talwelkar
Most non–small cell lung cancers (NSCLC) contain nontargetable mutations, including KRAS, TP53, or STK11/LKB1 alterations. By coupling ex vivo drug sensitivity profiling with in vivo drug response studies, we aimed to identify drug vulnerabilities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d26d521c92c9d7c4073c63d907f5285
https://doi.org/10.1158/1535-7163.c.6539226.v1
https://doi.org/10.1158/1535-7163.c.6539226.v1
Autor:
Tomi P. Mäkelä, Yan Yan, Benoit Viollet, Emmy W. Verschuren, Marc Foretz, Sarang S. Talwelkar, Ashwini S. Nagaraj, Kari Vaahtomeri, Iris P.L. Wong, Eva Domènech-Moreno, Sushil Tripathi, Pekka Päivinen, Yajing Gao
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf7d78d002e222ae30eb969056b2dcf
https://doi.org/10.1158/1078-0432.22483148.v1
https://doi.org/10.1158/1078-0432.22483148.v1
Autor:
Tomi P. Mäkelä, Yan Yan, Benoit Viollet, Emmy W. Verschuren, Marc Foretz, Sarang S. Talwelkar, Ashwini S. Nagaraj, Kari Vaahtomeri, Iris P.L. Wong, Eva Domènech-Moreno, Sushil Tripathi, Pekka Päivinen, Yajing Gao
Supplementary Tables S1-S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05f3b60ddeb33394f249a620d2b64aad
https://doi.org/10.1158/1078-0432.22483145.v1
https://doi.org/10.1158/1078-0432.22483145.v1
Autor:
Tomi P. Mäkelä, Yan Yan, Benoit Viollet, Emmy W. Verschuren, Marc Foretz, Sarang S. Talwelkar, Ashwini S. Nagaraj, Kari Vaahtomeri, Iris P.L. Wong, Eva Domènech-Moreno, Sushil Tripathi, Pekka Päivinen, Yajing Gao
Purpose:Mutations in STK11 (LKB1) occur in 17% of lung adenocarcinoma (LUAD) and drive a suppressive (cold) tumor immune microenvironment (TIME) and resistance to immunotherapy. The mechanisms underpinning the establishment and maintenance of a cold
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ed9939b234523c2dcc74834050a75e
https://doi.org/10.1158/1078-0432.c.6531086.v1
https://doi.org/10.1158/1078-0432.c.6531086.v1
Autor:
Tomi P. Mäkelä, Yan Yan, Benoit Viollet, Emmy W. Verschuren, Marc Foretz, Sarang S. Talwelkar, Ashwini S. Nagaraj, Kari Vaahtomeri, Iris P.L. Wong, Eva Domènech-Moreno, Sushil Tripathi, Pekka Päivinen, Yajing Gao
Supplementary Figures S1-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1af16f1984e30bc3cd20ebdf477eff
https://doi.org/10.1158/1078-0432.22483151.v1
https://doi.org/10.1158/1078-0432.22483151.v1
Autor:
Emmy W. Verschuren, Pekka Paivinen, Sushil Tripathi, Ashwini S. Nagaraj, Eva Domenech-Moreno, Tomi P. Mäkelä, Kari Vaahtomeri, Iris P. L. Wong, Sarang S. Talwelkar, Marc Foretz, Benoit Viollet, Yan Yan, Yajing Gao
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, 2021, pp.clincanres.2049.2021. ⟨10.1158/1078-0432.CCR-21-2049⟩
Clinical Cancer Research, American Association for Cancer Research, 2021, pp.clincanres.2049.2021. ⟨10.1158/1078-0432.CCR-21-2049⟩
Clinical Cancer Research, 2021, pp.clincanres.2049.2021. ⟨10.1158/1078-0432.CCR-21-2049⟩
Clinical Cancer Research, American Association for Cancer Research, 2021, pp.clincanres.2049.2021. ⟨10.1158/1078-0432.CCR-21-2049⟩
Purpose: Mutations in STK11 (LKB1) occur in 17% of lung adenocarcinoma (LUAD) and drive a suppressive (cold) tumor immune microenvironment (TIME) and resistance to immunotherapy. The mechanisms underpinning the establishment and maintenance of a cold